Concert Pharma (CNCE) Tops Q2 EPS by 3c

August 9, 2016 8:15 AM EDT
Get Alerts CNCE Hot Sheet
Trade CNCE Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Concert Pharma (NASDAQ: CNCE) reported Q2 EPS of ($0.60), $0.03 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $71 thousand versus the consensus estimate of $30 thousand.

For earnings history and earnings-related data on Concert Pharma (CNCE) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment